Mahinay, Joella Mae S.
HRN: 18-62-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/30/2023
PO
1 Tab
BID
SP NSVD; MSAF Thickly
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes